PD-1/PD-L1 Inhibitors May Improve Survival in NPC - Top_Thought_Leaders - MDSpire

PD-1/PD-L1 Inhibitors May Improve Survival in NPC

Meta-analysis suggests survival and response benefits alongside notable toxicity in recurrent or metastatic disease

  • By

  • Andrea Surnit

  • April 22, 2026

  • 2 min

Share

Top Thought Leaders in Oncology

Brief introduction explaining scope and methodology.

Original Source(s)

PD-1/PD-L1 Inhibitors May Improve Survival in NPC

  • by Andrea Surnit

  • April 22, 2026

Related Content

Advancing early detection during Head and Neck Cancer Awareness Month

April is Head and Neck Cancer Awareness Month, highlighting a diverse group of diseases that account for nearly 5% of all cancers in the United States.

  • by

  • April 8, 2026

  • 1 min
Bilateral Cervical Chondrocutaneous Branchial Remnants in a Child: A Case Report and Review of the Literature

Independent Association of Serum IgA Levels with Moderate-to-Severe Obstructive Sleep Apnea in Children with Adenotonsillar Hypertrophy